Home Featured

Featured

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept Pharmaceuticals (NASDAQ:ICPT) Gilead Sciences, Inc (NASDAQ:GILD) Clovis Oncology, Inc. (NASDAQ:CLVS) ...

David Rich - April 11, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right Now

Portola Pharmaceuticals Inc (NASDAQ:PTLA): A Misinterpretation Discount?

Weekly Biotech Report – Covering Clovis Oncology Inc (NASDAQ:CLVS) Chiasma Inc (NASDAQ:CHMA) Sarepta Therapeutics Inc (NASDAQ:SRPT) Collegium Pharmaceutical Inc. (NASDAQ:COLL)

INSYS is Targeting a $700 Million Market With Syndros

Why The Mast Therapeutics Inc (NYSEMKT:MSTX) Dip Might Be An Opportunity

- September 14, 2016 0

Weekly Biotech Report Part I – FDA To Decide On AstraZeneca...

David Rich - May 16, 2016 0

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

- March 14, 2016 0

VBL Therapeutics CEO tells us about their revolutionary approach to cure...

David Rich - September 16, 2016 0

Biotech and Opko Health, Inc. (NYSE:OPK) May Be Set For a...

Roger Hannington - February 22, 2016 0

Weekly Biotech Review Part I, Covering Titan Pharmaceuticals, Inc. (NASDAQ:TTNP)

David Rich - May 23, 2016 0

Why FDA Delay on Brodalumab Is Actually Great News For Valeant...

David Rich - November 29, 2016 0

Is Pain Therapeutics, Inc. (NASDAQ:PTIE) And Remoxy’s Long And Winding Road...

- July 4, 2016 1

Advisory Review Marks a Big Week for Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Roger Hannington - April 4, 2016 0

Why An Opko Health, Inc. (NYSE:OPK) Reversal Is Nigh

- February 16, 2016 0

12 3...142 Page 1 of 142

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.